The deal allows 71 cancer patients whose claims for the treatment were denied between January 2015 and March 2024 to receive reimbursement of at least $12,000 and up to $48,000 each. Patients won’t be required to show that their treatment was medically necessary in order to receive payment, according to a June 6 settlement motion.
The deal also requires Aetna to separately pay attorneys’ fees and settlement costs, and the patients’ ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
